Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

ANTXANTX
12 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in AN2 THERAPEUTICS INC

Yes. Renaissance Technologies holds 129,700 shares of ANTX (AN2 Therapeutics), worth $627,748, as of its Q2 2026 13F filing. It reduced the position by 69,100 shares (-34.8%) from Q1 2026. Renaissance Technologies has held ANTX since Q2 2024, across 9 quarterly 13F filings.

Current Value

$627,748

Current Shares

129,700

Total Value Change

+$428,748

Total Shares Change

+104,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
129,700
-34.8%
$627,7480.0%$4.84
0
2026-Q1
Decreased
198,800
-41.3%
$679,8960.0%$1.06
0
2025-Q4
Decreased
338,600
-12.2%
$386,0040.0%$1.08
0
2025-Q3
Decreased
385,597
-3.3%
$489,7080.0%$1.28
0
2025-Q2
Increased
398,854
+8.2%
$422,7850.0%$1.08
26
2025-Q1
Decreased
368,708
-36.4%
$501,4430.0%$1.39
0
2024-Q4
Increased
579,773
+36.8%
$800,0870.0%$1.41
32
2024-Q3
Increased
423,800
+2863.6%
$453,4660.0%$1.06
39
2024-Q2
New
14,300
-
$30,7450.0%$2.15
27
2022-Q4
Exited
0
-100.0%
$00.0%$9.53
0
2022-Q3
Decreased
22,000
-14.4%
$382,0000.0%$15.32
0
2022-Q2
New
25,700
-
$199,0000.0%$7.91
32

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used